Loading company…
Shenzhen Xbiome Biotech is an AI pharmaceutical company developing microbial treatments for intestinal and other systemic diseases.
Established in 2017 and based in Shenzhen, China, Shenzhen Xbiome Biotech Co., Ltd. is an artificial intelligence pharmaceutical company focused on intestinal drug development. Its treatments include fecal bacteria transplantation and formula bacteria. The core team comes from Harvard University, Massachusetts Institute of Technology, Stanford University and Johns Hopkins University. The company had completed 5 rounds of funding as of 2021, and its Series B funding is planned for clinical trials, US and China IND applications and candidate drug research.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in